Last reviewed · How we verify

NCT06071468: MISSION

Registry of the Patient Experience for Carpal Tunnel Release

Active, enrolled Last updated 6 February 2026
What this trial tests

trial testing UltraGuideCTR (Device) with Ultrasound Guided Carpal Tunnel Release (CTR-US) in Carpal Tunnel Syndrome in 2,000 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
26 January 2024
Primary endpoint
31 December 2027
31 December 2027

Quick facts

Lead sponsorSonex Health, Inc.
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment2,000
Start date26 January 2024
Primary completion31 December 2027
Estimated completion31 December 2027
Sites33 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Sonex Health, Inc.

Who can join

18 and older, any sex, with Carpal Tunnel Syndrome or CTS. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Multi-center study to collect large scale, multidimensional real-world data on patients undergoing carpal tunnel release (CTR).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Propensity Score-Matched Comparison of Ultrasound-Guided Versus Open Carpal Tunnel Release: Three-Month Outcomes From the MISSION Registry.
    Marwin VM, Lincoski CJ, Nelson JT, Watt JF, et al · · 2026 · PMID 41624979 · DOI 10.1016/j.jhsg.2025.100931

Verify or expand the search:

Other recruiting trials for Carpal Tunnel Syndrome

Currently open trials in the same condition.

Other Sonex Health, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06071468.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing